Litton Bionetics

Litton Bionetics — FDA 510(k) Submissions

Litton Bionetics has submitted 15 FDA 510(k) premarket notifications since 1978, of which 15 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Antigens, If, Toxoplasma Gondii, Antiserum, Fluorescent, Epstein-barr Virus, Antigen, Ha (including Ha Control), Rubella, Antigen, Cf (including Cf Control), Cytomegalovirus, Antigen, Cf (including Cf Control), Herpesvirus Hominis 1,2 . Use the specialty filter in the sidebar to narrow results.